Jose Tamayo, MD
Family Medicine · Jacksonville Beach, FLNPI 1912161340
Payments from drug & device makers
Across 140 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$491
- Novo Nordisk$290
- Pfizer$187
- Exact Sciences$164
- AstraZeneca$131
- Sanofi-aventis U.S. LLC$127
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,509100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 28 | $491 |
| Novo Nordisk | 15 | $290 |
| Pfizer | 11 | $187 |
| Exact Sciences | 9 | $164 |
| AstraZeneca | 9 | $131 |
| Sanofi-aventis U.S. LLC | 6 | $127 |
| Biohaven Pharmaceuticals, Inc. | 4 | $98 |
| Merck | 5 | $88 |
| AbbVie(2 entities) | 5 | $73 |
| Lilly USA, LLC | 4 | $71 |
| Amarin Pharma, Inc. | 4 | $65 |
| Dynavax Technologies Corporation | 2 | $63 |
| Boston Scientific | 2 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Astellas Pharma US Inc | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Eisai Inc. | 3 | $42 |
| IBSA Pharma Inc. | 2 | $32 |
| Bayer | 1 | $31 |
| Johnson & Johnson | 2 | $30 |
| GSK | 2 | $27 |
| Radius Health, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,517 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 135 | $199,222 |
| EliquisApixaban | 91 | $107,086 |
| JardianceEmpagliflozin | 63 | $81,578 |
| JanuviaSitagliptin Phosphate | 43 | $57,939 |
| MounjaroTirzepatide | 37 | $55,140 |
| XareltoRivaroxaban | 32 | $38,787 |
| FarxigaDapagliflozin Propanediol | 29 | $21,793 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 14 | $19,740 |
| LinzessLinaclotide | 13 | $12,853 |
| Omeprazole | 284 | $5,313 |
| TradjentaLinagliptin | 11 | $5,185 |
| Rosuvastatin Calcium | 369 | $4,709 |
| Levothyroxine Sodium | 419 | $4,357 |
| Atorvastatin Calcium | 461 | $4,189 |
| Gabapentin | 162 | $3,672 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $290 | $199,222135 claims |
| PfizerEliquis | $187 | $107,08691 claims |
| Boehringer IngelheimJardiance, Tradjenta | $491 | $86,76374 claims |
| MerckJanuvia | $88 | $57,93943 claims |
| Lilly USA, LLCMounjaro | $71 | $55,14037 claims |
| Johnson & JohnsonXarelto | $30 | $38,78732 claims |
| AstraZenecaFarxiga | $131 | $21,79329 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $127 | $19,74014 claims |
| AbbVieLinzess, Synthroid | $73 | $16,17566 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Jacksonville Beach
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.